Filter
361
Filtered Results: 361
Text search:
uzbekistan
Featured
Recommendations
24
New Publications
49
Language
Document type
No document type
209
Studies & Reports
90
Guidelines
17
Manuals
13
Strategic & Response Plan
13
Fact sheets
7
Training Material
6
Situation Updates
3
Resource Platforms
2
Infographics
1
Countries / Regions
Western and Central Europe
40
Global
25
Eastern Europe
23
Eastern Europe and Central Asia
13
Ukraine
12
Uzbekistan
12
Tajikistan
11
Asia
8
Russia
6
Germany
5
Kazakhstan
4
Kyrgyzstan
3
Armenia
3
South–East Asia Region
3
Colombia
2
Zimbabwe
2
Haiti
2
Latin America and the Carribbean
2
Western Pacific Region
2
Turkmenistan
2
Bangladesh
2
Ethiopia
2
India
2
North Macedonia
1
Nepal
1
Mexico
1
El Salvador
1
Serbia
1
Turkey
1
Ghana
1
Benin
1
Sierra Leone
1
Chile
1
Cameroon
1
Syria
1
Senegal
1
Congo-Brazzaville
1
Niger
1
Burkina Faso
1
Afghanistan
1
Peru
1
Guinea
1
Venezuela
1
Tanzania
1
Congo, Democratic Republic of
1
West and Central Africa
1
Middle East and North Africa
1
Uruguay
1
France
1
Spain
1
Belarus
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Argentina
1
Uganda
1
Nicaragua
1
Georgia
1
Honduras
1
Mali
1
Botswana
1
Zambia
1
Indonesia
1
Liberia
1
Madagascar
1
Pakistan
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
53
Clinical Guidelines
26
Key Resources
25
Public Health
20
Women & Child Health
19
Capacity Building
6
Pharmacy & Technologies
4
Toolboxes
HIV
68
TB
57
Mental Health
39
Disability
24
COVID-19
24
Planetary Health
18
Global Health Education
16
Rapid Response
15
Refugee
10
Pharmacy
8
Health Financing Toolbox
6
AMR
5
Natural Hazards
4
Conflict
4
Polio
3
Specific Hazards
2
Ebola & Marburg
2
Caregiver
2
NTDs
2
NCDs
2
Cholera
1
Social Ethics
1
Malaria
1
Zika
1
Innocenti Digest No. 13
Assessment in action series
Key Findings from Azerbaijan, Georgia, Kyrgyzstan, Russia, and Ukraine
Writing by Katya Burns
Editing by Paul Silva and Roxanne Saucier
WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC, 2017
Second editon
Health Evidence Network synthesis report 53
INT J TUBERC LUNG DIS 22(2):197–205 http://dx.doi.org/10.5588/ijtld.17.0245
Working towards better COVID-19 outcomes in the WHO European Region.From the first COVID-19 cases in Europe reported on
24 January 2020, the pandemic reached 1 million cases
within 3 months, 10 million cases within 8 months, and
100 million cases in Europe alone within 2 years. Over
the course o...
This Strategic Response Plan for the measles emergency in the WHO European Region (SRP) articulates the overall status of measles resurgence in the WHO European Region and the priority actions needed to ensure an effective response to interrupt transmission, save lives and reverse the regional trend...
Community pharmacists are the health professionals most accessible to the public and are a cornerstone of primary health care. The role of community pharmacists is expanding globally. This report provides an overview of existing components and provisions of the legal and regulatory framework for com...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
This report is part of the gender and noncommunicable diseases (NCDs) initiative launched by the WHO Regional Office for Europe, which aims to strengthen the response to NCDs through a gender approach. It is part of a series of country profiles and a synthesis report. The country profile of Ukraine ...
Chapter 1 provides new data on the latest developments in the global treatment effort, highlighting positive trends as well as aspects that require improvement. Chapter 2 summarizes the impact of the scale-up in reducing AIDS-related mortality and new HIV infections. Chapter 3 examines the sequence ...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Opiates, cocaine, cannabis
World Drug Report 2017
-3-
Accessed: 14.03.2019
Copenhagen, Denmark, 24–25 August 2017
